Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
Ray Therapeutics, a leading optogenetics company, today announced an upsized and oversubscribed $100M Series A […]
Sony and Astellas Enter into Collaborative Research Agreement to Discover a Novel ADC Platform for the Oncology Field
Sony Corporation and Astellas Pharma today announced that they have entered into a collaborative research […]
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
Personalis, the National Cancer Center, and Ono Pharmaceutical today announced they have entered into a […]
SynAct Pharma Appoints Björn Westberg as Chief Financial Officer (CFO)
SynAct Pharma has announced that Björn Westberg has been appointed Chief Financial Officer (CFO) and […]
Eikonoklastes Announces Formation of Scientific Advisory Board
Eikonoklastes Therapeutics, a biopharmaceutical company developing a novel gene therapy platform to discover and develop […]
SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform
SonoThera, a biotechnology company dedicated to treating the root cause of human diseases through genetic […]
LaNova Medicines Announces Global Exclusive License Agreement with AstraZeneca for LM-305, a Novel GPRC5D-Targeting Antibody Drug Conjugate
LaNova Medicines has announced it has entered into an exclusive license agreement with AstraZeneca, for […]
NeuroBo Pharmaceuticals Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors
NeuroBo Pharmaceuticals, a clinical-stage biotechnology company on a quest to transform cardiometabolic diseases, today announced […]
Rona Therapeutics and Keymed Biosciences Announce Collaboration to Discover and Develop First-in-class siRNA Therapeutics for Glomerulonephritis
Rona Therapeutics and Keymed Biosciences announced a collaboration to jointly discover and develop first-in-class siRNA […]
PTP Announces Partnership with TetraScience to Accelerate Innovation in Therapeutics
PTP, a leading cloud consultancy firm specializing in the life sciences industry, is pleased to […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more